Skip to content
logo acclivis group
  • About Us
  • News
  • Portfolio
  • Contact Us
Menu
  • About Us
  • News
  • Portfolio
  • Contact Us
mobile menu toggle

Portfolio

medtech healthier care

Medtech is New Zealand’s number one practice management software catering to General Practitioners, Specialists, Allied Health Professionals and the Ambulatory Care sector across Australasia.

drinfo

Dr Info is a population health and audit tool that helps General Practitioners provide better care to its patient through data analytics.

zsoftware

Z Software is Australia’s leading and fastest-growing pharmacy software company, providing fully-integrated dispensing, point-of sales, and office solutions to over 1,000+ pharmacies nation-wide.

Simple-Logo-300

Simple Retail is a provider of pharmacy dispensing, point-of-sale and multi-store head office solutions to Australian pharmacies.

Zed Technologies is a global diagnostic imaging exchange solution making the sharing of radiology results faster, safer and more secure.

medimap-logo

Medi-Map is Australasia’s leading medication management software streamlining and making the prescription, administration, documentation and supply of medication more transparent.

Portfolio

medtech healthier care

Medtech is New Zealand’s number one practice management software catering to General Practitioners, Specialists, Allied Health Professionals and the Ambulatory Care sector across Australasia.

drinfo

Dr Info is a population health and audit tool that helps General Practitioners provide better care to its patient through data analytics.

zsoftware

Z Software is Australia’s leading and fastest-growing pharmacy software company, providing fully-integrated dispensing, point-of sales, and office solutions to over 1,000+ pharmacies nation-wide.

Simple-Logo-300

Simple Retail is a provider of pharmacy dispensing, point-of-sale and multi-store head office solutions to Australian pharmacies.

Zed Technologies is a global diagnostic imaging exchange solution making the sharing of radiology results faster, safer and more secure.

medimap-logo

Medi-Map is Australasia’s leading medication management software streamlining and making the prescription, administration, documentation and supply of medication more transparent.

logo acclivis group

Acclivis Group is a private investment and advisory firm exclusively focused on healthcare software and technology companies.

CONTINUE READING
CONTACT US
Linkedin-in
Site map
  • Home
  • About us
  • Portfolio
  • News
  • Contact us
  • Disclaimer
Contact
  • info@acclivis.group
©2025 Acclivis Group. All rights reserved.
  • MADE WITH
  • BY DIGITAL RECIPE

Acclivis Group Management Pty Ltd (CAR) is a corporate authorised representative of Boutique Capital Pty Ltd (BCPL) AFSL 508011, CAR Number 001293067. CAR is the investment manager of the Acclivis Investment I Fund (Fund).

To the extent to which this document contains advice it is general advice only and has been prepared by the CAR for individuals identified as wholesale investors for the purposes of providing a financial product or financial service, under Section 761G or Section 761GA of the Corporations Act 2001 (Cth).

The information herein is presented in summary form and is therefore subject to qualification and further explanation. The information in this document is not intended to be relied upon as advice to investors or potential investors and has been prepared without taking into account personal investment objectives, financial circumstances or particular needs. Recipients of this document are advised to consult their own professional advisers about legal, tax, financial or other matters relevant to the suitability of this information.

The investment summarised in this document is subject to known and unknown risks, some of which are beyond the control of CAR and their directors, employees, advisers or agents. CAR does not guarantee any particular rate of return or the performance of the Fund, nor does CAR and its directors personally guarantee the repayment of capital or any particular tax treatment. Past performance is not indicative of future performance.

The materials contained herein represent a general summary of CAR’s current portfolio construction approach. CAR is not constrained with respect to any investment decision making methodologies and may vary from them materially at its sole discretion and without prior notice to investors. Depending on market conditions and trends , CAR may pursue other objectives or strategies considered appropriate and in the best interest of portfolio performance.

There are risks involved in investing in the CAR’s strategy. All investments carry some level of risk, and there is typically a direct relationship between risk and return. We describe what steps we take to mitigate risk (where possible) in the Fund’s Information Memorandum. It is important to note that despite taking such steps, the CAR cannot mitigate risk completely.

This document was prepared as a private communication to clients and is not intended for public circulation or publication or for the use of any third party, without the approval of CAR. Whilst this report is based on information from sources which CAR considers reliable, its accuracy and completeness cannot be guaranteed. Data is not necessarily audited or independently verified. Any opinions reflect CAR’s judgment at this date and are subject to change. CAR has no obligation to provide revised assessments in the event of changed circumstances. To the extent permitted by law, BCPL, CAR and their directors and employees do not accept any liability for the results of any actions taken or not taken on the basis of information in this report, or for any negligent misstatements, errors or omissions.

This Document is informational purposes only and is not a solicitation for units in the Fund. Application for units in the Fund can only be made via the Fund’s Information Memorandum and Application Form.

white site icon
  • About Us
  • News
  • Portfolio
  • Contact Us
  • About Us
  • News
  • Portfolio
  • Contact Us
  • info@acclivis.group